A trial to test the effectiveness of a novel non-invasive treatment for fatty liver disease.

Currently recruiting

About this study

Eligible participants will be taking the investigational medication for a duration of 24 weeks and will need to return to the clinic every four (4) weeks for safety assessments. Participants will receive compensation for time and travel expenses.

Anticipated enrolment close date: 30 June 2023

Contact the Clinical Trials Centre for more information.

Contact us to find out more about this research study, quoting reference number 2021.011

Who can take part

To be eligible for the study, volunteers must be:

  • At least 18 years of age
  • Diagnosed with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) but not cirrhosis
  • Able to comply with study procedures
  • Able to attend the clinic for study assessments every 4 weeks for the duration of the study

What's involved

  • Safety assessment visit every 4 weeks
  • Medical history
  • Physical exam
  • Electrocardiogram
  • Weight, height, blood pressure, pulse, heart rate
  • Health questionnaires
  • Fibroscan
  • Blood samples
  • Urine test
  • Abdominal scan
Person handling test tubes for research


All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.

This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.

Contact us
Clinical Trials Centre
(03) 9342 8076
(03) 9342 8076
The RMH Parkville
Level 2 South West
300 Grattan St, Parkville, Victoria